Erratum: Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial The ideas and ...

The Kansas City Chiefs’ offense operated like a knife through warm butter on Sunday night. In a crazy 33-30 overtime win over the Indianapolis Colts, the Chiefs had 523 yards of total offense. Patrick ...

HONG KONG, Sept. 21, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that nearly 30 clinical studies of its globally first-in-class bispecific antibodies will be ...

Kansas City Chiefs fans couldn't have asked for a better debut from running back Kenneth Walker III on Monday night. The Super Bowl LX MVP single-handedly carried an otherwise stagnant Chiefs offense ...

As high-school math students gear up to buy the newest version of Texas Instruments’ TI-84 graphic calculator, cheaper upstarts are trying to break the company’s decades-old grip on the market. Texas ...

The Fort Hood-based corps spent the first half of this year under Army Europe and Asia, as the Army continues to restructure. By Nicholas Slayton Published Aug 9, 2026 2:14 PM EDT Add Task & Purpose ...

APPOMATTOX COUNTY, Va. (WSET) — The Appomattox County Sheriff's Office is mourning the loss of one of its own after he was killed in the line of duty on Thursday. The sheriff's office announced on ...

APPOMATTOX COUNTY, Va. — An Appomattox County Sheriff's Office Deputy was killed in the line of duty on Thursday. According to a news release from Sheriff Robert Richardson, Deputy Burlie W. Duvall ...

Rachel Burchfield is the contributing royals editor at InStyle, where she covers news about the British royal family on a daily basis, including the work and wardrobes of Kate Middleton and Meghan ...

“As announced in our earnings release, we anticipate presenting top line results from Voyage, our first Phase III study of DT120 ODT in generalized anxiety disorder, or GAD, during the week of August ...

As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the superiority of replacing ...